Acorda Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Acorda Therapeutics

05/08/2021 22:40

* Acorda Therapeutics Inc  ACOR.OQ  reported a quarterly
adjusted loss of $1.87​​ per share for the quarter ended in
June. The lone analyst forecast for the quarter was for a loss
of $2.09 per share.
* Revenue fell 5.4% to $31.79 million from a year ago;  analysts
expected $29.94 million. 
* Acorda Therapeutics Inc's reported EPS for the quarter was a
loss of $2.29​.
* The mean earnings estimate of analysts had fallen by
about 30.6% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Acorda Therapeutics Inc shares had fallen by 21.4% this
quarter and lost 9.4% so far this year.
* The company reported a quarterly loss of $22.86 million.
* Wall Street's median 12-month price target for Acorda
Therapeutics Inc is $10.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 5 at 09:40 p.m.  ​All
figures in US dollars unless otherwise stated